• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

21世纪血管通路的发展全景。

The evolving panorama of vascular access in the 21st century.

作者信息

Neyra Nilda Roxana, Wazir Shoaib

机构信息

Arizona Kidney Disease and Hypertension Center (AKDHC), Phoenix, AZ, United States.

出版信息

Front Nephrol. 2022 Oct 26;2:917265. doi: 10.3389/fneph.2022.917265. eCollection 2022.

DOI:10.3389/fneph.2022.917265
PMID:37675010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10479615/
Abstract

There are three major types of hemodialysis vascular access: hemodialysis catheters, arteriovenous grafts, and arteriovenous fistulas. Arteriovenous fistulas provide the best access due to their reliability and long-term patency. They are recommended by the current Kidney Disease Outcomes Quality Initiatives (K-DOQI) guidelines; however, not all patients benefit from arteriovenous fistulas due to poor maturation or a lack of adequate vasculature. Currently, hemodialysis is initiated catheters in the majority of patients. Catheters are associated with high morbidity and mortality due to infection, lower quality of dialysis, and the development of central vein stenosis. The varied responses of patients to the different access types exemplify the need to choose the "right access for the right patient" based on scores that can predict death risk and progression of chronic kidney disease. Additionally, vascular access, often referred to as the "Achilles' heel" of hemodialysis patients, represents a significant percentage of the Medicare budget that continues to increase yearly. The purpose of this paper is to review the current literature on the management of vascular access complications and infection treatment and prevention. The paper also explores emerging research regarding the devices and methods to improve access outcomes such as early cannulation arteriovenous grafts, endovascular arteriovenous fistula creation, and regenerative grafts with resorbable scaffolds, among others. The data were collected through literature searches PubMed, Athens and web search engines.

摘要

血液透析血管通路主要有三种类型

血液透析导管、动静脉移植物和动静脉内瘘。动静脉内瘘因其可靠性和长期通畅性而提供了最佳的通路。它们是目前肾脏病预后质量倡议(K-DOQI)指南所推荐的;然而,并非所有患者都能从动静脉内瘘中获益,原因是成熟不良或缺乏足够的脉管系统。目前,大多数患者开始血液透析时使用导管。由于感染、透析质量较低以及中心静脉狭窄的发生,导管与高发病率和死亡率相关。患者对不同通路类型的不同反应表明,需要根据能够预测死亡风险和慢性肾脏病进展的评分,为“合适的患者选择合适的通路”。此外,血管通路常被称为血液透析患者的“阿喀琉斯之踵”,在医疗保险预算中占相当大的比例,且该比例逐年持续增加。本文的目的是综述当前关于血管通路并发症管理以及感染治疗与预防的文献。本文还探讨了有关改善通路结局的装置和方法的新兴研究,如早期插管动静脉移植物、血管内动静脉内瘘创建以及带有可吸收支架的再生移植物等。数据是通过在PubMed、Athens以及网络搜索引擎上进行文献检索收集的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8a/10479615/acdcc08af6fe/fneph-02-917265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8a/10479615/eb41bfc8ab7e/fneph-02-917265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8a/10479615/424cabe94f31/fneph-02-917265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8a/10479615/acdcc08af6fe/fneph-02-917265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8a/10479615/eb41bfc8ab7e/fneph-02-917265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8a/10479615/424cabe94f31/fneph-02-917265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8a/10479615/acdcc08af6fe/fneph-02-917265-g003.jpg

相似文献

1
The evolving panorama of vascular access in the 21st century.21世纪血管通路的发展全景。
Front Nephrol. 2022 Oct 26;2:917265. doi: 10.3389/fneph.2022.917265. eCollection 2022.
2
Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.美国血液透析血管通路的利用、通畅性和相关并发症。
J Vasc Surg. 2018 Oct;68(4):1166-1174. doi: 10.1016/j.jvs.2018.01.049.
3
Innovations in vascular access for hemodialysis.血液透析血管通路的创新。
Kidney Int. 2019 May;95(5):1053-1063. doi: 10.1016/j.kint.2018.11.046. Epub 2019 Mar 4.
4
Management of Immature Arteriovenous Fistulas.不成熟动静脉瘘的处理。
Cardiovasc Intervent Radiol. 2023 Sep;46(9):1125-1135. doi: 10.1007/s00270-023-03440-y. Epub 2023 May 4.
5
Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.通过积极的通路监测和血管内治疗,上肢Vectra血管通路移植物与转位肱动脉-贵要静脉内瘘的等效二级通畅率。
J Vasc Surg. 2008 Feb;47(2):407-14. doi: 10.1016/j.jvs.2007.09.061. Epub 2007 Dec 26.
6
A randomised control trial protocol of MuST for vascular access cannulation in hemodialysis patients (MuST Study): contributions for a safe nursing intervention.MuST 用于血液透析患者血管通路置管的随机对照试验方案(MuST 研究):为安全护理干预提供的贡献。
BMC Nephrol. 2022 Jun 21;23(1):218. doi: 10.1186/s12882-022-02842-3.
7
Failure of arteriovenous fistula maturation: an unintended consequence of exceeding dialysis outcome quality Initiative guidelines for hemodialysis access.动静脉内瘘成熟失败:超出透析结局质量改进计划血液透析通路指南的意外后果。
J Vasc Surg. 2003 Sep;38(3):439-45; discussion 445. doi: 10.1016/s0741-5214(03)00732-8.
8
Maturation of arteriovenous fistulas in patients with ventricular assist devices.使用心室辅助装置患者动静脉内瘘的成熟情况
J Vasc Access. 2020 Mar;21(2):176-179. doi: 10.1177/1129729819865706. Epub 2019 Jul 31.
9
New Devices and Technologies for Hemodialysis Vascular Access: A Review.新的血液透析血管通路设备和技术:综述。
Am J Kidney Dis. 2021 Jul;78(1):116-124. doi: 10.1053/j.ajkd.2020.11.027. Epub 2021 May 6.
10
Vascular access for hemodialysis: Current practice in Vietnam.血液透析的血管通路:越南的当前实践。
J Vasc Access. 2019 May;20(1_suppl):20-23. doi: 10.1177/1129729818771883. Epub 2018 Dec 31.

引用本文的文献

1
Peritoneal Dialysis As Salvage Therapy in a High-Risk Patient With Failed Hemodialysis Access: A Case Report.腹膜透析作为血液透析通路失败的高危患者的挽救治疗:一例报告
Cureus. 2025 Jun 24;17(6):e86681. doi: 10.7759/cureus.86681. eCollection 2025 Jun.
2
Epidemiology of Vascular Access in Patients Undergoing Chronic Hemodialysis Treatment in Greece.希腊接受慢性血液透析治疗患者的血管通路流行病学
J Clin Med. 2025 Jun 27;14(13):4571. doi: 10.3390/jcm14134571.
3
Prediction of Vascular Access Stenosis by Lightweight Convolutional Neural Network Using Blood Flow Sound Signals.

本文引用的文献

1
Dialysis Care around the World: A Global Perspectives Series.《全球透析护理:全球视角系列》
Kidney360. 2021 Feb 26;2(4):604-607. doi: 10.34067/KID.0001082021. eCollection 2021 Apr 29.
2
Central Vein Stenosis in Hemodialysis Patients Following Initial Tunneled Central Vein Catheter Placement.初次放置隧道式中心静脉导管后血液透析患者的中心静脉狭窄。
Kidney360. 2021 Oct 21;3(1):99-102. doi: 10.34067/KID.0005202021. eCollection 2022 Jan 27.
3
Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access.
基于血流声信号的轻量化卷积神经网络对血管通路狭窄的预测。
Sensors (Basel). 2024 Sep 12;24(18):5922. doi: 10.3390/s24185922.
4
The utilization of renal dialysis: a comprehensive study in Saudi Arabia.沙特阿拉伯肾脏透析的利用情况:一项综合研究。
BMC Public Health. 2024 Jul 16;24(1):1914. doi: 10.1186/s12889-024-19450-5.
5
Therapeutic strategies based on non-ionizing radiation to prevent venous neointimal hyperplasia: the relevance for stenosed arteriovenous fistula, and the role of vascular compliance.基于非电离辐射预防静脉内膜增生的治疗策略:对狭窄动静脉内瘘的相关性及血管顺应性的作用
Front Cardiovasc Med. 2024 Feb 5;11:1356671. doi: 10.3389/fcvm.2024.1356671. eCollection 2024.
接受生物工程人脱细胞血管用于透析通路的终末期肾病患者的五年结局
EJVES Vasc Forum. 2022 Jan 10;54:58-63. doi: 10.1016/j.ejvsvf.2022.01.003. eCollection 2022.
4
Catheter-Associated Bloodstream Infections among Patients on Hemodialysis: Progress before and during the COVID-19 Pandemic.血液透析患者导管相关血流感染:COVID-19 大流行前后的进展。
Clin J Am Soc Nephrol. 2022 Mar;17(3):429-433. doi: 10.2215/CJN.11360821. Epub 2022 Feb 2.
5
Catheter-Related Right Atrial Thrombus Requiring Surgical Embolectomy.需要手术取栓的导管相关右心房血栓
Cureus. 2021 Sep 1;13(9):e17641. doi: 10.7759/cureus.17641. eCollection 2021 Sep.
6
Percutaneous Arteriovenous Fistula Creation with the WavelinQ 4-French EndoAVF System: A Single-Center Retrospective Analysis of 30 Patients.经 WavelinQ 4 French 端动静脉瘘系统行经皮动静脉瘘创建:30 例患者的单中心回顾性分析。
J Vasc Interv Radiol. 2022 Jan;33(1):33-40. doi: 10.1016/j.jvir.2021.09.021. Epub 2021 Oct 2.
7
Percutaneous arteriovenous fistula creation with the 4F WavelinQ EndoAVF System.使用 4F WavelinQ EndoAVF 系统行经皮动静脉瘘创建术。
J Vasc Surg. 2022 Mar;75(3):1038-1046.e3. doi: 10.1016/j.jvs.2021.09.025. Epub 2021 Oct 1.
8
Effect of far infrared therapy on arteriovenous fistula maturation, survival and stenosis in hemodialysis patients, a randomized, controlled clinical trial: the FAITH on fistula trial.远红外线治疗对血液透析患者动静脉瘘成熟、通畅及狭窄的影响:一项随机对照临床试验:FAITH 瘘管试验。
BMC Nephrol. 2021 Aug 21;22(1):283. doi: 10.1186/s12882-021-02476-x.
9
The role of stents in hemodialysis vascular access.支架在血液透析血管通路中的作用。
J Vasc Access. 2023 Jan;24(1):107-116. doi: 10.1177/11297298211015069. Epub 2021 May 17.
10
Comparison of surgical versus percutaneously created arteriovenous hemodialysis fistulas.手术与经皮穿刺建立动静脉血液透析瘘的比较。
J Vasc Surg. 2021 Jul;74(1):209-216. doi: 10.1016/j.jvs.2020.12.086. Epub 2021 Feb 4.